경두개 도플러 초음파 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the transcranial doppler ultrasound market size is expected to grow from USD 489.69 million in 2025 to USD 525.19 million in 2026 and is forecast to reach USD 745.39 million by 2031 at 7.25% CAGR over 2026-2031.

This report is Segmented by Application (Sickle Cell Disease, Acute Ischemic Stroke, Intracranial Steno-Occlusive Disease), Device Type (Stand-Alone Systems, Portable/Hand-held Systems), End User (Hospitals, Diagnostic Laboratories, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Transcranial Doppler Ultrasound Market Trends and Insights

Rising Global Stroke Incidence & Aging Demographics Elevating Demand for Rapid Neuro-vascular Screening

The worldwide rise in ischemic stroke cases, now surpassing 11.9 million annually, is intensifying demand for fast, bedside cerebrovascular assessments. Aging populations in Europe, Japan, and the United States magnify this trend as hypertension and obesity prevalence remain high. Governments and health systems are prioritizing early-stage detection, placing Transcranial Doppler Ultrasound market solutions at the center of stroke prevention pathways. Large data sets linking middle cerebral artery flow patterns to functional outcomes strengthen clinical confidence and reimbursement prospects. Consequently, procurement budgets for portable neuro-vascular scanners are rising in neurology, cardiology, and emergency departments.

Proliferation of Comprehensive Stroke Centers & Tele-stroke Networks Enhancing TCD Utilization

National stroke strategies are accelerating licensure of advanced thrombectomy hubs, each requiring around-the-clock neuro-diagnostics. In France, mechanical thrombectomy capacity remains at 7,500 procedures versus a 20,500-case potential, driving hospitals to integrate automated Transcranial Doppler Ultrasound market platforms for collateral-flow triage. Tele-stroke networks further leverage real-time Doppler waveforms to guide patient transfer decisions. These service expansions shorten door-to-reperfusion intervals and underscore the modality's critical role, directly lifting device sales and service contracts.

High Operator Dependency and Learning Curve Limiting Standardized Interpretations Across Sites

Traditional systems require expert sonographers to identify acoustic windows; waveform variability of 40% day-to-day in severe TBI illustrates the challenge. Differing pressure-flow relationship categories complicate treatment algorithms. These technical hurdles deter smaller hospitals from purchasing systems and restrain broad reimbursement approvals. Robotics and AI partially offset the problem but do not fully eliminate the need for structured credentialing.

Other drivers and restraints analyzed in the detailed report include:

1. Expansion of Point-of-Care Ultrasound Programs Boosting Neuro-sonology Training & Adoption
2. Technological Convergence Improving Diagnostic Yield & Accessibility
3. Reimbursement Variability Across Regions Constraining Capital Procurement Budgets

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Acute ischemic stroke accounted for the largest transcranial doppler ultrasound market share at 34.15% in 2025, supported by guideline endorsements for collateral-flow mapping prior to mechanical reperfusion. Integration into multimodal stroke pathways sustains equipment refresh cycles across comprehensive centers. Traumatic brain injury monitoring is the fastest climber with an 8.62% CAGR, propelled by defense-sector research and sports-medicine protocols. Pediatric sickle-cell screening remains a stable revenue stream anchored by mandatory annual protocols, while cerebral vasospasm surveillance after subarachnoid hemorrhage holds steady due to strong evidence backing daily Doppler checks.

Continuous innovation overlays all applications. AI-augmented decision support now suggests shunt gradings within seconds, narrowing interpretation variance. Cloud-based reporting accelerates neurosurgeon consults, allowing rapid escalation to angiography when flow velocities exceed critical thresholds. Collectively, these advances deepen clinical reliance on transcranial doppler ultrasound market solutions and extend monitoring beyond acute episodes into secondary-prevention regimes.

Complete Report Scope:

• By Application
  • Sickle Cell Disease
  • Acute Ischemic Stroke
  • Intracranial Steno-Occlusive Disease
  • Cerebral Vasospasm Monitoring
  • Traumatic Brain Injury Management
• By Device Type
  • Stand-alone Systems
  • Portable/Hand-held Systems
• By End User
  • Hospitals
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers
  • Academic & Research Institutes
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America led with 41.32% revenue in 2025, anchored by dense stroke-center networks and structured neuro-critical-care pathways. Favorable CPT codes for sickle-cell and carotid assessments support baseline volumes, though wider indication gaps remain. Pilot programs equipping paramedic teams with lightweight scanners illustrate the region's appetite for pre-hospital adoption.

Europe ranks second, benefiting from universal coverage and robust research funding. France's under-utilization of thrombectomy underscores latent demand for diagnostic capacity expansion; the United Kingdom's GBP 6.5 (USD 8.7) million ultrasound brain-computer interface trial underscores public-sector commitment to frontier neuro-technologies. Meanwhile, Germany and the Nordics pursue national registry initiatives that integrate Doppler metrics, fostering evidence-based reimbursement dialogues.

Asia-Pacific is the fastest-growing territory at 7.95% CAGR as stroke incidence rises sharply and governments invest in tele-medicine. China's provincial stroke-care maps mandate Doppler access in secondary hospitals, while India's new stroke units boost procurement of portable consoles suitable for district facilities. Japan advances preventive screening programs targeting silent cerebral infarcts in seniors, amplifying recurring probe and maintenance revenues. Smaller but strategically important markets in the Middle East & Africa and South America embrace public-private financing models to import Transcranial Doppler Ultrasound market technologies alongside broader critical-care upgrades.

1. NovaSignal Corp.
2. Viasonix
3. Rimed
4. DWL Elektronische Systeme GmbH (Compumedics)
5. Probo Medical
6. Brawn Medical Ltd.
7. Delica Medical
8. Atys Medical
9. Natus Medical (Nicolet)
10. GE Healthcare
11. Koninklijke Philips
12. Fujifilm Sonosite
13. Mindray
14. EDAN Instruments
15. Compumedics Ltd.
16. EB Neuro
17. Neurolite AG
18. Konica Minolta Healthcare India
19. Shenzhen Delica Medical Equipment

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Global Stroke Incidence & Aging Demographics Elevating Demand for Rapid Neuro-vascular Screening
  • 4.2.2 Proliferation of Comprehensive Stroke Centers & Tele-stroke Networks Enhancing TCD Utilization
  • 4.2.3 Expansion of Point-of-Care Ultrasound Programs Boosting Neuro-sonology Training & Adoption
  • 4.2.4 Technological Convergence Improving Diagnostic Yield & Accessibility
  • 4.2.5 Rising Emphasis on Preventive Neurological Screening
  • 4.2.6 Adoption of Portable & AI-Integrated TCD Systems
• 4.3 Market Restraints
  • 4.3.1 High Operator Dependency and Learning Curve Limiting Standardized Interpretations Across Sites
  • 4.3.2 Reimbursement Variability Across Regions Constraining Capital Procurement Budgets
  • 4.3.3 Increasing Availability & Cost Decline of Alternative Neuro-imaging Modalities
  • 4.3.4 Lack of Standardized Protocols Across Clinical Settings
• 4.4 Technological Outlook
• 4.5 Porter's Five Forces Analysis
  • 4.5.1 Threat of New Entrants
  • 4.5.2 Bargaining Power of Buyers/Consumers
  • 4.5.3 Bargaining Power of Suppliers
  • 4.5.4 Threat of Substitute Products
  • 4.5.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value in USD)

• 5.1 By Application
  • 5.1.1 Sickle Cell Disease
  • 5.1.2 Acute Ischemic Stroke
  • 5.1.3 Intracranial Steno-Occlusive Disease
  • 5.1.4 Cerebral Vasospasm Monitoring
  • 5.1.5 Traumatic Brain Injury Management
• 5.2 By Device Type
  • 5.2.1 Stand-alone Systems
  • 5.2.2 Portable/Hand-held Systems
• 5.3 By End User
  • 5.3.1 Hospitals
  • 5.3.2 Diagnostic Laboratories
  • 5.3.3 Ambulatory Surgical Centers
  • 5.3.4 Academic & Research Institutes
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East & Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East & Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 NovaSignal Corp.
  • 6.3.2 Viasonix
  • 6.3.3 Rimed
  • 6.3.4 DWL Elektronische Systeme GmbH (Compumedics)
  • 6.3.5 Probo Medical
  • 6.3.6 Brawn Medical Ltd.
  • 6.3.7 Delica Medical
  • 6.3.8 Atys Medical
  • 6.3.9 Natus Medical (Nicolet)
  • 6.3.10 GE Healthcare
  • 6.3.11 Koninklijke Philips N.V.
  • 6.3.12 Fujifilm Sonosite
  • 6.3.13 Mindray Medical International
  • 6.3.14 EDAN Instruments
  • 6.3.15 Compumedics Ltd.
  • 6.3.16 EB Neuro S.p.A.
  • 6.3.17 Neurolite AG
  • 6.3.18 Konica Minolta Healthcare India
  • 6.3.19 Shenzhen Delica Medical Equipment

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment